Cita APA

Mukohara, T., Nagai, S., Mukai, H., Namiki, M., & Minami, H. (2011). Eribulin mesylate in patients with refractory cancers: A Phase I study. Springer US.

Citación estilo Chicago

Mukohara, Toru, Shunji Nagai, Hirofumi Mukai, Masayuki Namiki, y Hironobu Minami. Eribulin Mesylate in Patients With Refractory Cancers: A Phase I Study. Springer US, 2011.

Cita MLA

Mukohara, Toru, et al. Eribulin Mesylate in Patients With Refractory Cancers: A Phase I Study. Springer US, 2011.